The Role of Sarcosine Metabolism in Prostate Cancer Progression

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Abate-Shen, 2000, Molecular genetics of prostate cancer, Genes Dev, 14, 2410, 10.1101/gad.819500

Abate-Shen, 2009, Diagnostics: the prostate-cancer metabolome, Nature, 457, 799, 10.1038/457799a

Sreekumar, 2009, Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression, Nature, 457, 910, 10.1038/nature07762

Jentzmik, 2011, Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression, J Urol, 185, 706, 10.1016/j.juro.2010.09.077

Cao, 2011, Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine, Prostate Cancer Prostatic Dis, 14, 166, 10.1038/pcan.2011.2

Cao, 2011, A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer, Prostate, 71, 700, 10.1002/pros.21286

Bianchi, 2011, Fully automated solid-phase microextraction-fast gas chromatography-mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sediments, Anal Chim Acta, 707, 197, 10.1016/j.aca.2011.09.015

Jentzmik, 2010, Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours, Eur Urol, 58, 12, 10.1016/j.eururo.2010.01.035

Lucarelli, 2012, Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml, Prostate, 72, 1611, 10.1002/pros.22514

Stabler, 2011, Serum methionine metabolites are risk factors for metastatic prostate cancer progression, PLoS One, 6, e22486, 10.1371/journal.pone.0022486

Kerr, 1972, Competing methyltransferase systems, J Biol Chem, 247, 4248, 10.1016/S0021-9258(19)45067-9

Yeo, 1994, Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver, Proc Natl Acad Sci USA, 91, 210, 10.1073/pnas.91.1.210

Porter, 1985, Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver, Arch Biochem Biophys, 243, 396, 10.1016/0003-9861(85)90516-8

Dodt, 2000, l-pipecolic acid oxidase, a human enzyme essential for the degradation of l-pipecolic acid, is most similar to the monomeric sarcosine oxidases, Biochem J, 345, 487, 10.1042/bj3450487

Ateeq, 2011, Therapeutic targeting of SPINK1-positive prostate cancer, Sci Transl Med, 3, 72ra17, 10.1126/scitranslmed.3001498

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262

Mehra, 2005, Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis, Cancer Res, 65, 11259, 10.1158/0008-5472.CAN-05-2495

Varambally, 2002, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, 419, 624, 10.1038/nature01075

Yu, 2007, Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer, Cancer Cell, 12, 419, 10.1016/j.ccr.2007.10.016

Cao, 2008, Repression of E-cadherin by the polycomb group protein EZH2 in cancer, Oncogene, 27, 7274, 10.1038/onc.2008.333

Varambally, 2008, Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer, Science, 322, 1695, 10.1126/science.1165395

Asangani, 2013, Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer, Mol Cell, 49, 80, 10.1016/j.molcel.2012.10.008

van der Horst, 2004, TaqMan-based quantification of invasive cells in the chick embryo metastasis assay, Biotechniques, 37, 940, 10.2144/04376ST02

Risk, 2010, Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect, Clin Cancer Res, 16, 5414, 10.1158/1078-0432.CCR-10-0272

Song, 2011, The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer, Mod Pathol, 24, 1272, 10.1038/modpathol.2011.76

Huang, 2008, Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma, J Gastroenterol Hepatol, 23, 1384, 10.1111/j.1440-1746.2008.05488.x

Huang, 2007, Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer, Clin Cancer Res, 13, 1412, 10.1158/1078-0432.CCR-06-1551

Chen, 2011, The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels, J Biol Chem, 286, 16091, 10.1074/jbc.M110.193805